David Close
Company: AstraZeneca
Job title: Executive Director, Early Clinical Development Immunology
Seminars:
Panel Discussion: Improving Clinical Endpoints & Optimizing Trial Design 2:00 pm
Moving from oncology to autoimmunity, do we need to adapt clinical trial design? Are basket trials the way forward? How do we improve communication between hematology, rheumatology, and oncology disciplines? What should clinical readouts and endpoints look like for autoimmune disease? How can we implement surrogate endpoints?Read more
day: Conference Day Two